Cargando…
Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of tumors, with aggressive clinical course that renders prognostication and choice of treatment strategy difficult. Chemo-immunotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (R-CHOP) is the cu...
Autores principales: | Marchesi, Francesco, Regazzo, Giulia, Palombi, Francesca, Terrenato, Irene, Sacconi, Andrea, Spagnuolo, Manuela, Donzelli, Sara, Marino, Mirella, Ercolani, Cristiana, Di Benedetto, Anna, Blandino, Giovanni, Ciliberto, Gennaro, Mengarelli, Andrea, Rizzo, Maria Giulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930939/ https://www.ncbi.nlm.nih.gov/pubmed/29716630 http://dx.doi.org/10.1186/s13046-018-0768-5 |
Ejemplares similares
-
Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells
por: Spagnuolo, Manuela, et al.
Publicado: (2019) -
A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas
por: Regazzo, Giulia, et al.
Publicado: (2016) -
PB2416: EFFICACY AND SAFETY OF BIOSIMILAR PEGFILGRASTIM AFTER AUTOLOGOUS STEM CELL TRANSPLANT: A COMPARATIVE STUDY WITH BIOSIMILAR FILGRASTIM, LENOGRASTIM AND ORIGINATOR PEGFILGRASTIM
por: Marchesi, Francesco, et al.
Publicado: (2023) -
microRNA-378a-5p iS a novel positive regulator of melanoma progression
por: Tupone, Maria Grazia, et al.
Publicado: (2020) -
A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting
por: Terrenato, Irene, et al.
Publicado: (2022)